CVS Caremark (CVS) Tops Q1 EPS by 2c; Boosts FY12 adj.-EPS Outlook; Guides Q2

Article Stock Quotes (1) Comments (0)

CVS Caremark (NYSE: CVS) reported Q1 EPS of $0.65, $0.02 better than the analyst estimate of $0.63. Revenue for the quarter came in at $30.8 million versus the consensus estimate of $30.31 billion.

Retail Pharmacy segment same stores sales increased 8.4%.

CVS Caremark sees FY2012 EPS of $3.23-$3.33, versus the consensus of $3.27.

CVS Caremark sees Q2 2012 EPS of $0.78-$0.80, versus the consensus of $0.74.

For earnings history and earnings-related data on CVS Caremark (CVS) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
• Infoblox (BLOX) Tops Q3 EPS by 5c; Issues Outlook
• Gap, Inc. (GPS) Tops Q1 EPS by 2c; Reaffirms Outlook

Create E-mail Alert Related Categories

Earnings, Guidance, Hot Guidance

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?